STAA (Staar Surgical Co) Risk Assessment


STAA Staar Surgical Co STAA
83 GF Score
Price $28.15
GF Value $31.73
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Staar Surgical Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Staar Surgical Co is: Moderate Risk: Sensitive, better choose undervalued stock.

Staar Surgical Co  (NAS:STAA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Staar Surgical Co Risk Assessment Related Terms

STAA vs BLFS, ATRC, KMTS: Risk Assessment Comparison

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staar Surgical Co Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Risk Assessment falls into.


STAA
83GF Score
Staar Surgical Co STAA
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Staar Surgical Co (STAA) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of $28.15 is trading 11.3% below its estimated GF Value™ of $31.73. GuruFocus considers Staar Surgical Co to be Modestly Undervalued.

Key valuation signals for STAA:

  • Risk Assessment:
  • GF Value™: $31.73 vs. price of $28.15 (11.3% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Staar Surgical Co Business Description

Other Exchanges SR3:Germany
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
83GF Score

Get the complete analysis for STAA

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.15
Price
$31.73
GF Value